While globally the incidence of Kaposi sarcoma is decreasing with increasing ART coverage [31,32], we observed increasing prevalence over time, reaching 3.6% among patients enrolled in 2014 with low CD4 count, most likely due to improved detection, although the limitations of physician-diagnosis are known [33]. The gene discussed is CD4; the disease is Kaposi's sarcoma.